A structured approach for identifying disease analogs for pulmonary arterial hypertension
{{output}}
Drug manufacturers often use disease analogs to describe diseases-particularly rare diseases-to payers, policymakers, and stakeholders. However, these comparisons are typically anecdotal. We propose a 4-step, systematic approach to identify disease analogs bas... ...
